| Glen A Green, MD | |
|
601 Childrens Ln, Norfolk, VA 23507-1910 | |
| (757) 668-7456 | |
| (757) 668-9255 |
| Full Name | Glen A Green |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 601 Childrens Ln, Norfolk, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477505907 | NPI | - | NPPES |
| 0000931601 | Medicaid | DE | |
| 006722164 | Medicaid | VA | |
| 119981100 | Medicaid | MD | |
| 1802339000 | Medicaid | WV | |
| 0018694320001 | Medicaid | PA | |
| 890677B | Medicaid | NC |
| Entity Name | Childrens Specialty Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255354130 PECOS PAC ID: 5890788764 Enrollment ID: O20040406001195 |
News Archive
More American workers and job applicants are testing positive for prescription opiates, according to U.S. general workforce data in the 2009 annual Drug Testing Index™ (DTI) released today by Quest Diagnostics Incorporated, the nation's leading provider of diagnostic testing, information and services. Results from more than 5.5 million urine drug tests reveal an 18 percent jump in opiate positives in the general U.S. workforce in a single year (2008 to 2009), and a more than 40 percent climb from 2005 to 2009.
Researchers at the University of Gothenburg, Sweden, have developed new methods for analysing medical databases that can be used to identify diagnostic markers more quickly and to personalise medication for allergic disorders. They could also reduce the need for animal trials in clinical studies.
Delaying clamping of the umbilical cord after birth benefits newborn babies, according to a systematic review published in The Cochrane Library. The authors found babies' blood and iron levels were healthier when the cord was clamped later.
Celator Pharmaceuticals today announced that interim safety and efficacy data from its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML) were presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana (ASH Abstract # 1033).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glen A Green, MD Po Box 79137, Baltimore, MD 21279-0137 Ph: (757) 668-7200 | Glen A Green, MD 601 Childrens Ln, Norfolk, VA 23507-1910 Ph: (757) 668-7456 |
News Archive
More American workers and job applicants are testing positive for prescription opiates, according to U.S. general workforce data in the 2009 annual Drug Testing Index™ (DTI) released today by Quest Diagnostics Incorporated, the nation's leading provider of diagnostic testing, information and services. Results from more than 5.5 million urine drug tests reveal an 18 percent jump in opiate positives in the general U.S. workforce in a single year (2008 to 2009), and a more than 40 percent climb from 2005 to 2009.
Researchers at the University of Gothenburg, Sweden, have developed new methods for analysing medical databases that can be used to identify diagnostic markers more quickly and to personalise medication for allergic disorders. They could also reduce the need for animal trials in clinical studies.
Delaying clamping of the umbilical cord after birth benefits newborn babies, according to a systematic review published in The Cochrane Library. The authors found babies' blood and iron levels were healthier when the cord was clamped later.
Celator Pharmaceuticals today announced that interim safety and efficacy data from its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML) were presented at the 51st American Society of Hematology (ASH) Annual Meeting in New Orleans, Louisiana (ASH Abstract # 1033).
› Verified 8 days ago
Joshua Wayne Gollub, Pediatrics Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7000 | |
Stephen C. Restaino, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7179 Fax: 757-668-9810 | |
Michael Lee Smith, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7456 Fax: 757-668-9255 | |
Phyllis R. Hope, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7456 Fax: 757-668-9255 | |
Linda D Pegram, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7007 Fax: 757-668-8658 | |
Ernette Yvonne Benson-foulk, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6345 Center Dr, Building 14, Norfolk, VA 23502 Phone: 757-461-4027 Fax: 757-461-8821 | |
Monica G Baker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7456 Fax: 757-668-9255 |